Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Advances in PediatricsReferences
- Swine influenza A (H1N1) infection in two children—Southern California, March-April 2009.MMWR Morb Mortal Wkly Rep. 2009; 58: 400-402
- Outbreak of swine-origin influenza A (H1N1) virus infection—Mexico, March-April 2009.MMWR Morb Mortal Wkly Rep. 2009; 58: 467-470
- The 2009 H1N1 influenza outbreak in its historical context.J Clin Virol. 2009; 45: 174-178
- Historical perspective-emergence of influenza A (H1N1) viruses.N Engl J Med. 2009; 361: 279-285
- Emergence of a novel swine-origin influenza A (H1N1) virus in humans.N Engl J Med. 2010; 360: 2605-2615
- 2009 H1N1 influenza: a twenty-first century pandemic with roots in the early twentieth century.Am J Med Sci. 2010; 340: 202-208
- Characterization of the 1918 influenza virus polymerase genes.Nature. 2005; 437: 889-893
- Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans.Science. 2009; 325: 197-201
- The A/2009 H1N1 influenza virus pandemic.(update September 2009) Available at: (Accessed November 8, 2010)
- Updating the accounts: global mortality of the 1918–1920 “Spanish” influenza pandemic.Bull Hist Med. 2002; 76: 105-115
- Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China.N Engl J Med. 2009; 361: 2507-2517
- Novel influenza A (H1N1): clinical presentation, diagnosis and management.Pediatr Emerg Care. 2009; 25: 791-796
- Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009.N Engl J Med. 2009; 361: 1935-1944
- Updated CDC estimates of 2009 H1N1 influenza cases, hospitalizations and deaths in the United States.(Available at)http://www.cdc.gov/h1n1flu/estimates_2009_h1n1.htm(Accessed November 22, 2010)Date: April 2009-April 10, 2010
- (California Pandemic (H1N1) working group). Children hospitalized with 2009 novel influenza A(H1N1) in California.Arch Pediatr Adolesc Med. 2010; 164: 1023-1031
- Clinical and epidemiologic characteristics of children hospitalized with 2009 pandemic H1N1 influenza A infection.Pediatr Infect Dis J. 2010; 29: 591-594
Custodio H, Carmen M, Bailey C, et al. Hospitalized children infected with the novel H1N1 (nH1N1) influenza: comparison of the ICU to non-ICU patients. Poster presentation, Infectious Diseases Society of America Annual Meeting. Vancouver British Columbia (Canada); October 21–24, 2010.
- Epidemiologic and clinical features among patients hospitalized in Wisconsin with 2009 H1N1 influenza A virus infections, April to August 2009.WMJ. 2010; 109: 201-208
- Pandemic A (H1N1) 2009 influenza; a review of the southern hemisphere experience.Epidemiol Infect. 2011; 139: 27-40
- Epidemiological aspects of 2009 H1N1 influenza: the accumulating experience from the northern hemisphere.Eur J Clin Microbiol Infect Dis. 2010; 29: 1327-1347
- Cross reactive antibody responses to the 2009 pandemic H1N1 influenza virus.N Engl J Med. 2009; 361: 1945-1952
- Influenza vaccination in pregnancy: current evidence and selected national policies.Lancet Infect Dis. 2008; 8: 44-52
- Receptor-binding specificity of pandemic influenza A (H1N1) 2009 virus determined by carbohydrate microarray.Nat Biotechnol. 2009; 27: 797-799
- Correlates of protection induced by vaccination.Clin Vaccine Immunol. 2010; 17: 1055-1065
- Influenza vaccine-outmaneuvering antigenic shift and drift.N Engl J Med. 2004; 350: 218-220
- Influenza vaccine manufacture: keeping up with the change.J Infect Dis. 2009; 200: 835-837
- Response to a monovalent 2009 influenza A (H1N1) vaccine.N Engl J Med. 2009; 361: 2405-2413
- Immunogenicity of a monovalent 2009 influenza A(H1N1) in infants and children: a randomized trial.JAMA. 2010; 303: 37-46
- Immune response after a single vaccination against 2009 influenza A H1N1 in the USA: a preliminary report of two randomized controlled phase 2 trials.Lancet. 2010; 375: 41-48
- Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: a multi-center, double-blind, randomized, placebo-controlled trial.Lancet. 2010; 375: 56-66
- A single dose of unadjuvanted novel 2009H1N1 vaccine is immunogenic and well tolerated in young and elderly adults.J Infect Dis. 2010; 202: 1327-1337
- Partial protection of seasonal trivalent inactivated vaccine against novel pandemic influenza A/H1N1 2009: case control study in Mexico City.BMJ. 2009; 339: b3928
- Protective efficacy of seasonal influenza vaccination against seasonal and pandemic influenza virus infection during 2009 in Hong Kong.Clin Infect Dis. 2010; 51: 1370-1379
- Pandemic and seasonal H1N1 influenza haemagglutinin-specific T cell responses elicited by seasonal influenza vaccination.Vaccine. 2010; 28: 8258-8267
- Inactivated seasonal influenza vaccines increase serum antibodies to the neuraminidase of pandemic influenza A (H1N1)2009 virus in an age-dependant manner.J Infect Dis. 2010; 202: 1634-1638
- Effectiveness of 2008–2009 trivalent influenza against 2009 pandemic influenza A (H1N1)—United States, May-June 2009.MMWR Morb Mortal Wkly Rep. 2009; 58: 1241-1245
- Adverse reaction of influenza A (H1N1) 2009 virus vaccination in pregnant women and its effect on newborns.Vaccine. 2010; 28: 7455-7456
- Surveillance for pediatric deaths associated with 2009 pandemic influenza A (H1N1) virus infection-United States, April-August 2009.MMWR Morb Mortal Wkly Rep. 2009; 58: 941-947
- Helping mothers prevent influenza illness in their infants.Pediatrics. 2010; 126: 1008-1011
- Maternal influenza vaccination and effect on influenza virus infection in young infants.Arch Pediatr Adolesc Med. 2011; 165: 104-111https://doi.org/10.1001/archpediatrics.2010.192
- Mandatory vaccination of health care workers.N Engl J Med. 2009; 361: 2015-2017
- Policy statement—recommendation for mandatory influenza immunization of all health care personnel.Pediatrics. 2010; 126: 809-815
- Revised SHEA position paper: influenza vaccination of healthcare personnel.Infect Control Hosp Epidemiol. 2010; 31: 987-995
- Safety and immunogenicity following administration of a live attenuated monovalent 2009 H1N1 influenza vaccine to children and adults in two randomized controlled trials.PLoS One. 2010; 5: e13755
- Adverse events following influenza A (H1N1) 2009 monovalent vaccines reported to the Vaccine Adverse Event Reporting System, United States, October 1, 2009-January 31, 2010.Vaccine. 2010; 28: 7248-7255
- Preliminary results: surveillance for Guillain-Barre syndrome after receipt of influenza A (H1N1) 2009 monovalent vaccine-United States 2009-2010.MMWR Morb Mortal Wkly Rep. 2010; 59: 657-661
- Swine flu outbreak. China first to vaccinate against novel H1N1 virus.Science. 2009; 325: 1482-1483
- FDA 2009 H1N1 vaccine questions and answers.(Available at:) (Accessed November 25, 2010)
- The 2009 A (H1N1) influenza virus pandemic: a review.Vaccine. 2010; 28: 4895-4905
- Public views of the UK media and government reaction to the 2009 swine flu pandemic.BMC Public Health. 2010; 10: 697
- Population and risk group uptake of H1N1 influenza vaccine in mainland France 2009–2010: results of a national vaccination campaign.Vaccine. 2010; 28: 8157-8161
- Pandemic (H1N1) 2009 influenza vaccine uptake in pregnant women entering the 2010 influenza season in Western Australia.Med J Aust. 2010; 193: 405-407
- Knowledge, attitudes and anxiety toward influenza A/H1N1 vaccination of healthcare workers in Turkey.BMC Infect Dis. 2010; 10: 281
- Perceived seriousness of seasonal and A(H1N1) influenzas, attitude toward vaccination and vaccine uptake among US adults: does the source of information matter?.Prev Med. 2010; 51: 185-187
- Practice and child characteristics associated with influenza vaccine uptake in young children.Pediatrics. 2010; 126: 665-673
- Household transmission of the 2009 pandemic A/H1N1 influenza virus: elevated laboratory-confirmed secondary attack rates and evidence of asymptomatic infections.Clin Infect Dis. 2010; 51: 1033-1041
- Household transmission of 2009 pandemic influenza A (H1N1) virus in the United States.N Engl J Med. 2009; 361: 2619-2627
- Comparative epidemiology of pandemic and seasonal influenza A in households.N Engl J Med. 2010; 362: 2175-2184
- Pandemic (H1N1) 2009 virus outbreak in a school in London, April-May 2009: an observational study.Epidemiol Infect. 2010; 138: 183-191
- Household transmission of 2009 influenza A (H1N1) virus after a school based outbreak In New York City, April-May 2009.J Infect Dis. 2010; 201: 984-992
- Closure of schools during an influenza pandemic.Lancet Infect Dis. 2009; 9: 473-481
- Update: influenza activity—United States 2009-10 season.MMWR Morb Mortal Wkly Rep. 2010; 59: 901-908
- Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010.MMWR Recomm Rep. 2010; 59: 1-62
- Policy statement—recommendations for prevention and control of influenza in children, 2010-2011.Pediatrics. 2010; 126: 816-826
- Safety and immunogenicity of trivalent and inactivated influenza vaccine in infants: a randomized, double-blind, placebo-controlled study.Pediatr Infect Dis J. 2010; 29: 105-110
- Influenza activity—United States and worldwide, June 13-September 25, 2010.MMWR Morb Mortal Wkly Rep. 2010; 59: 1270-1273
- National, state and local area vaccination coverage among adolescents aged 13–17 years—United States, 2009.MMWR Morb Mortal Wkly Rep. 2010; 59: 1018-1023
- Whooping cough outbreak hits several US states.BMJ. 2010; 341: c4627
- The role of adults in household outbreaks of pertussis.Int J Infect Dis. 2010; 14: e111-e114
- Investigation on a pertussis outbreak in a military school: risk factors and approach to vaccine efficacy.Vaccine. 2010; 28: 5147-5152
- Use of mass Tdap vaccination to control an outbreak of pertussis in a high school—Cook County, Illinois, September 2006-January 2007.MMWR Morb Mortal Wkly Rep. 2008; 57: 796-799
- California Department of Health.(Available at:) (Accessed April 13, 2011)
- Infant pertussis: who was the source?.Pediatr Infect Dis J. 2004; 23: 985-989
- The case for maternal vaccination against pertussis.Lancet Infect Dis. 2007; 7: 614-624
- Prevention of pertussis, tetanus and diphtheria among pregnant and post partum women and their infants: recommendations of the Advisory Committee on Immunization Practices.MMWR Recomm Rep. 2008; 57: 1-51
- ACIP Presentation slides: October 2010 meeting.(Available at:) (Accessed November 25, 2010)
FDA Approval Letter-Menactra. Available at: http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm131181.htm. Accessed November 25, 2010.
FDA Approval Letter-Menveo. Available at: http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm201343.htm. Accessed November 25, 2010.
- Comparison of the safety and immunogenicity of an investigational and a licensed quadrivalent meningococcal conjugate vaccine in children 2–10 years of age.Vaccine. 2010; 28: 7865-7872
- Revised recommendations of the Advisory Committee on Immunization Practices to vaccinate all persons aged 11–18 years with meningococcal conjugate vaccine.MMWR Morb Mortal Wkly Rep. 2007; 56: 794-795
- ACIP Presentation Slides October 2010.(Available at:) (Accessed November 25, 2010)
- Revised Recommendations from the Advisory Committee on Immunization Practices (ACIP) for revaccination of persons at prolonged increased risk for meningococcal disease.MMWR Morb Mortal Wkly Rep. 2010; 58: 1042-1043
- Henoch-Schonlein purpura and polysaccharide meningococcal vaccine.Pediatrics. 2010; 126: e325-e329
- Review of meningococcal group B vaccines.Clin Infect Dis. 2010; 50: S54-S65
- Multicenter, open-label, randomized phase II controlled trial of an investigational recombinant Meningococcal serogroup B vaccine with and without outer membrane vesicles, administered in infancy.Clin Infect Dis. 2010; 51: 1127-1137
- Immunogenicity of two investigational serogroup B meningococcal vaccines in the first year of life: a randomized comparative trial.Pediatr Infect Dis J. 2010; 29: e71-e79
FDA Approval Letter-Cervarix. Available at: http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm186959.htm. Accessed November 27, 2010.
- Human papillomavirus and HPV vaccines: a review.Bull World Health Organ. 2007; 85: 719-726
- FDA licensure of bivalent human papillomavirus (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices.MMWR Morb Mortal Wkly Rep. 2010; 59: 626-629
- FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices.MMWR Morb Mortal Wkly Rep. 2010; 59: 630-632
- Economic evaluation of human papillomavirus vaccination in developed countries.Public Health Genomics. 2009; 12: 343-351
- Predictors of HPV vaccine acceptability: a theory-informed systematic review.Prev Med. 2007; 45: 107-114
- Parental decision making about HPV vaccine.Cancer Epidemiol Biomarkers Prev. 2010; 19: 2187-2198
- Reasons for non vaccination against HPV and future vaccination intentions in 19-26-year-old women.BMC Womens Health. 2010; 10: 27
- Acceptability of human papillomavirus vaccine for males: a review of the literature.J Adolesc Health. 2010; 46: 113-123
- Adolescent immunization: the next big thing?.Arch Dis Child. 2010; (Accessed online November 28, 2010)https://doi.org/10.1136/adc.2010.192070
- Human papillomavirus vaccination practices: a survey of US physicians 18 months after licensure.Pediatrics. 2010; 126: 425-433
- Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine.N Engl J Med. 2003; 348: 1737-1746
- Impact of childhood vaccination on racial disparities in invasive Streptococcus pneumoniae infections.JAMA. 2004; 291: 2197-2203
- Changing epidemiology of invasive pneumococcal disease among older adult in the era of pediatric pneumococcal conjugate vaccine.JAMA. 2005; 294: 2043-2051
- Effect of introduction of the pneumococcal vaccine on drug-resistant Streptococcus pneumoniae.N Engl J Med. 2006; 354: 1455-1463
- Invasive pneumococcal disease among infants before and after introduction of pneumococcal conjugate vaccine.JAMA. 2006; 295: 1668-1674
- Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine.J Infect Dis. 2010; 201: 32-41
- Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998–2004.J Infect Dis. 2007; 196: 1346-1354
FDA Approval Letter- Prevnar 13. Available at: http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm201741.htm. Accessed November 28, 2010.
- Licensure of a 13-valent pneumococcal conjugate vaccine (PCV13) and recommendations for use among children—Advisory Committee on Immunization Practices (ACIP), 2010.MMWR Morb Mortal Wkly Rep. 2010; 59: 258-261
- Recommendations for the prevention of invasive Streptococcus pneumoniae infections in infants and children: use of 13-valent pneumococcal conjugate vaccine (PCV13) and pneumococcal polysaccharide vaccine (PPSV23).Pediatrics. 2010; 126: 186-190
- Updated recommendations for prevention of invasive pneumococcal disease among adults using the 23-valent pneumococcal polysaccharide vaccine (PPSV23).MMWR Morb Mortal Wkly Rep. 2010; 59: 1102-1106
- Rotavirus Approval. 2008 Biologicals License Applications Approval.(Available at:) (Accessed November 29, 2010)
- Effectiveness of the pentavalent rotavirus vaccine in preventing gastroenteritis in the United States.Pediatrics. 2010; 125: e208-e213
- Effectiveness of pentavalent rotavirus vaccine in a large urban population in the United States.Pediatrics. 2010; 125: e199-e207
- Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomized double-blind placebo controlled trial.Lancet. 2010; 376: 615-623
- Rotarix in developing countries: paving the way for inclusion in national childhood immunization programs in Africa.J Infect Dis. 2010; 202: S80-S86
- Update on rotavirus trends and the importance of surveillance.Pediatr Infect Dis J. 2010; 29: 1130-1132
- FDA: benefits of rotavirus vaccination outweigh potential contamination risk.JAMA. 2010; 304: 30-31
- Addition of severe combined immunodeficiency as a contraindication for administration of rotavirus vaccine.MMWR Morb Mortal Wkly Rep. 2010; 59: 687-688
- Vaccine preventable diseases: statement regarding Rotarix and Rotateq rotavirus vaccines and intussusception.(Available at:) (Accessed December 8, 2010)
- Immunogenicity and safety of an investigational combined Haemophilus influenzae type B—Neisseria meningitis serogroups C and Y-tetanus toxoid conjugate vaccine.Pediatr Infect Dis J. 2010; (Available at:) (Accessed November 27, 2010)
- Combined Haemophilus type b and Neisseria meningitides serogroup C (HibMenC) or serogroup C and Y-tetanus toxoid conjugate (and HibMenCY) vaccines are well tolerated and immunogenic when administered according to the 2,3,4 months schedule with a fourth dose at 12–18 months of age.Hum Vaccin. 2010; 6: 640-651
- Invasive Haemophilus influenza type B disease in five children—Minnesota, 2008.MMWR Morb Mortal Wkly Rep. 2009; 58: 58-60
- Immunogenicity and safety of GSK Biologicals’ Infanrix Haxa in infants.(Available at:) (Accessed November 28, 2010)
- Hepatitis A in internationally adopted children: screening for acute and previous infections.Pediatrics. 2010; 126: e1039-e1044
- Medical evaluation of internationally adopted children for infectious diseases.in: Pickering L.K. Baker C.J. Kimberlin D.W. Red Book 2009: Report of the Committee on Infectious Diseases. American Academy of Pediatrics, Elk Grove Village (IL)2009: 177-184
- Infected countries.(Available at:) (Accessed November 28, 2010)
The GAVI Alliance. Available at: http://www.gavialliance.org/resources/GAVI_Alliance_Nov_2010.pdf. Accessed November 28, 2010.
- Progress towards control of rubella and prevention of congenital rubella syndrome—worldwide, 2009.MMWR Morb Mortal Wkly Rep. 2010; 59: 1307-1310